Merck Sharpe & Dohme (UK) Limited
Supplier — contracts won
£1.0bnTotal value£1,007,473,199 across every award on file
5Awardspublished since 4 July 2024
Who buys from them
| Buyer | Awards | Value |
|---|---|---|
| NHS England | 2 | £1.0bn |
| UK Health Security Agency | 3 | £3 |
Every award on file
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 28 Oct 2024 | NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024 | NHS England | Gilead Sciences Limited +12 | £626.5m |
| 22 Jul 2024 | NHS Branded Medicines Tranche Framework for London and South of EnglandEast Midlands | NHS England | Sun Pharma UK Ltd +28 | £381.0m |
| 10 Oct 2025 | Human Papillomavirus (2025) | UK Health Security Agency | Merck Sharpe & Dohme (UK) Limited | £1 |
| 10 Oct 2025 | Human Papillomavirus (2025) | UK Health Security Agency | Merck Sharpe & Dohme (UK) Limited | £1 |
| 7 Aug 2025 | Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025) | UK Health Security Agency | Merck Sharpe & Dohme (UK) Limited +1 | £1 |
Organisations are grouped by name, because the notices carry no identifier that appears on all of them. A body that publishes under two spellings will appear twice; two different companies with the same trading name will appear as one. Check the individual notices before drawing a conclusion.